Brazil refuses to open investigation into Bolsonaro over vaccine

Brazil refuses to open investigation into Bolsonaro over vaccine

According to the news portal G1, prosecutors announced that they would appeal against Weber’s decision, which stated that the ruler had “no right to lethargy” before being informed of a possible crime.

He insisted that the head of state had an obligation to activate the supervisory bodies when he was informed of an alleged crime.

According to the law, evasions consist of “unreasonably delaying, refraining from, or taking an official action contrary to the express provision of the law in order to satisfy personal interests or feelings”.

The starting point is what was revealed on June 25 in the Senate commission evaluating the government’s pandemic management by Health Department official Ricardo Miranda, director of import logistics, and his brother, Deputy Louis Miranda.

Both stated that in March of the same year they had warned Bolsonaro about suspicions of corruption in the negotiations for the acquisition of Covaxin, an anti-Covid-19 drug.

Among the irregularities pointed out by the brothers is the international bill with a forecast of $45 million, which was not foreseen in the original contract.

Likewise, other accounts with a provision for fewer doses than those provided for in the contract and on behalf of a Singapore-based company not mentioned in the original agreement.

The investigation aims to clarify whether or not Bolsonaro was at fault regarding the alleged vaccine procurement anomalies, and whether the president would personally benefit in any way.

For three months, the government has not communicated openly about the Covaxin allegations.

After the Miranda brothers made it public, the federal administration presented three versions.

The scandal sparked the ex-military’s unpopularity in opinion polls ahead of October’s election, amid a disease that has so far claimed 659,241 deaths and 29,882,397 infections.

mem/ocs